- Previous Rank304
- Revenues ($M)$10,412.0
- Revenue Percent Change6.9%
- Profits ($M)$259.0
- Profits Percent Change-80.2%
- Assets ($M)$22,549.0
- Employees58,000
The global contract-research firm conducts clinical trials and other activities for health care companies and has approximately 58,000 employees in more than 100 countries.
Company Info
| CEO | Ari Bousbib |
| CEO Title | Chairman, President & Chief Executive Officer |
| Sector | Health Care |
| Industry | Health Care: Pharmacy and Other Services |
| HQ Location | Durham, N.C. |
| Website | http://www.iqvia.com |
| Years on Fortune 500 List | 6 |
| Employees | 58,000 |
IQVIA Holdings Rank History
placeholder
Key Financials (Last Fiscal Year)
| $ millions | % change | |
|---|---|---|
| Revenues ($M) | $10,412.0 | 6.9% |
| Profits ($M) | $259.0 | -80.2% |
| Assets ($M) | $22,549.0 | - |
| Total Stockholder Equity ($M) | $6,714.0 | - |
Profit Ratios
| Profit as % of Revenues | 2.5% |
| Profits as % of Assets | 1.1% |
| Profits as % of Stockholder Equity | 3.9% |
Earnings Per Share (Last Fiscal Year)
| Earnings Per Share ($) | 1.24 |
| EPS % Change (from 2017) | -78.9% |
| EPS % Change (5 year annual rate) | -6.9% |
| EPS % Change (10 year annual rate) | - |
Total Return
| Total Return to Investors (2018) | 18.7% |
| Total Return to Investors (5 year, annualized) | 20.2% |
| Total Return to Investors (10 year, annualized) | - |